GreenLight Biosciences Holdings PBC (GRNA) Forecast, Price Target & Analyst Ratings
NASDAQ:GRNA • US39536G1058
0.2995 USD
0 (-0.03%)
At close: Jul 21, 2023
0.2995 USD
0 (0%)
After Hours: 7/21/2023, 8:00:02 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GreenLight Biosciences Holdings PBC (GRNA).
Forecast Snapshot
Consensus Price Target
$0.46
+ 53.26% Upside
Next Earnings Forecast
Release DateAug 14, 2023
PeriodQ2 / 2023
EPS Estimate-$0.27
Revenue Estimate510K
ChartMill Buy Consensus
45.71%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.46
Upside
+ 53.26%
From current price of $0.30 to mean target of $0.46, Based on 7 analyst forecasts
Low
$0.30
Median
$0.46
High
$0.63
Price Target Revisions
1 Month
0.00%
3 Months
-80.43%
Price Target Summary
7 analysts have analysed GRNA and the average price target is 0.46 USD. This implies a price increase of 53.26% is expected in the next year compared to the current price of 0.2995.
The average price target has been revised downward by 80.43% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.71%
GRNA was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about GRNA.
In the previous month the buy percentage consensus was at a similar level.
GRNA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-05-31 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2022-12-08 | Canaccord Genuity | Initiate | Buy |
| 2022-10-14 | Credit Suisse | Initiate | Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateAug 14, 2023
PeriodQ2 / 2023
EPS Estimate-$0.27
Revenue Estimate510K
Revenue Q2Q-71.15%
EPS Q2QN/A
Number of Analysts4
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
-58.24%
EPS (3 Months)
-7.82%
Next Earnings Summary
GRNA is expected to report earnings on 8/14/2023. The consensus EPS estimate for the next earnings is -0.27 USD and the consensus revenue estimate is 510.00K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.747M -41.79% | 1.595M -8.70% | 6.78M 325.08% | 7.242M 6.81% | 17.969M 148.12% | |
| EBITDA YoY % growth | N/A | -102.786M | -154.884M -50.69% | -127.194M 17.88% | -126.174M 0.80% | |
| EBIT YoY % growth | -52.284M -79.04% | -108.558M -107.63% | -162.96M -50.11% | -136.374M 16.31% | -137.394M -0.75% | |
| Operating Margin | -2,992.79% | -6,806.14% | -2,403.54% | -1,883.10% | -764.62% | |
| EPS YoY % growth | N/A | N/A | N/A | -0.85 26.28% | -0.83 1.74% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.27 | -0.26 10.32% | -0.24 4.12% |
| Revenue Q2Q % growth | 510K -71.15% | 510K -70.55% | 2.244M -25.77% |
| EBITDA Q2Q % growth | -38.006M 20.56% | -37.781M -24.44% | -38.108M -27.42% |
| EBIT Q2Q % growth | -30.906M 40.52% | -30.294M 16.40% | -29.478M 22.39% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
GreenLight Biosciences Holdings PBC / GRNA Forecast FAQ
What is the average price target for GreenLight Biosciences Holdings PBC (GRNA) stock?
7 analysts have analysed GRNA and the average price target is 0.46 USD. This implies a price increase of 53.26% is expected in the next year compared to the current price of 0.2995.
What is the next earnings date for GRNA stock?
GreenLight Biosciences Holdings PBC (GRNA) will report earnings on 2023-08-14, after the market close.
What are the consensus estimates for GreenLight Biosciences Holdings PBC (GRNA) next earnings?
The consensus EPS estimate for the next earnings of GreenLight Biosciences Holdings PBC (GRNA) is -0.27 USD and the consensus revenue estimate is 510.00K USD.
How many analysts cover GreenLight Biosciences Holdings PBC (GRNA) stock?
The number of analysts covering GreenLight Biosciences Holdings PBC (GRNA) is 7.